Literature DB >> 16251207

Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant.

Bernd Frank1, Kari Hemminki, Barbara Wappenschmidt, Alfons Meindl, Rüdiger Klaes, Rita K Schmutzler, Peter Bugert, Michael Untch, Claus R Bartram, Barbara Burwinkel.   

Abstract

Dysregulation of apoptosis plays a crucial role in carcinogenesis. As part of death receptor- and mitochondrion-mediated apoptosis, the homologues caspases 10 and 8 may act as low-penetrance breast cancer (BC) susceptibility genes. In death receptor-mediated apoptosis, engagement of death receptors by their ligands involves the assembly of the death-inducing signalling complex (DISC). In mitochondrion-mediated apoptosis, the release of cytochrome c into the cytosol results in apoptosome formation. Recruitment of both caspases 10 and 8 (CASP10 and CASP8, respectively) to DISC and apoptosome leads to their activation by dimerization. We investigated the influence of the coding CASP10 variant V410I (G1228A) by performing a case-control study - using 511 familial BC cases and 547 control subjects - on BC risk and revealed a significant association of V410I with a reduced risk (OR = 0.62, 95% CI = 0.43-0.88, P = 0.0076) related to the number of variant alleles (P(trend) = 0.0039). As CASP10 and CASP8 functionally co-operate during apoptosis, we analysed the mutual effect of both CASP10 V410I and CASP8 D302H, resulting in a significant association between the number of the variant alleles I410 and H302 and a highly decreased familial BC risk (OR = 0.35, P(trend) = 0.007), pointing to the interaction between the CASP10 and CASP8 polymorphisms in breast carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16251207     DOI: 10.1093/carcin/bgi248

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  18 in total

1.  Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions.

Authors:  David C Qian; Jinyoung Byun; Younghun Han; Casey S Greene; John K Field; Rayjean J Hung; Yonathan Brhane; John R Mclaughlin; Gordon Fehringer; Maria Teresa Landi; Albert Rosenberger; Heike Bickeböller; Jyoti Malhotra; Angela Risch; Joachim Heinrich; David J Hunter; Brian E Henderson; Christopher A Haiman; Fredrick R Schumacher; Rosalind A Eeles; Douglas F Easton; Daniela Seminara; Christopher I Amos
Journal:  Hum Mol Genet       Date:  2015-10-19       Impact factor: 6.150

Review 2.  Caspases and cancer.

Authors:  M Olsson; B Zhivotovsky
Journal:  Cell Death Differ       Date:  2011-04-01       Impact factor: 15.828

3.  Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma.

Authors:  Chunying Li; Hui Zhao; Zhibin Hu; Zhensheng Liu; Li-E Wang; Jeffrey E Gershenwald; Victor G Prieto; Jeffrey E Lee; Madeleine Duvic; Elizabeth A Grimm; Qingyi Wei
Journal:  Hum Mutat       Date:  2008-12       Impact factor: 4.878

4.  The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck.

Authors:  Chunying Li; Jiachun Lu; Zhensheng Liu; Li-E Wang; Hui Zhao; Adel K El-Naggar; Erich M Sturgis; Qingyi Wei
Journal:  Cancer Prev Res (Phila)       Date:  2010-01-19

5.  Caspase polymorphisms and genetic susceptibility to multiple myeloma.

Authors:  H Dean Hosgood; Dalsu Baris; Yawei Zhang; Yong Zhu; Tongzhang Zheng; Meredith Yeager; Robert Welch; Shelia Zahm; Stephen Chanock; Nathaniel Rothman; Qing Lan
Journal:  Hematol Oncol       Date:  2008-09       Impact factor: 5.271

6.  Caspase-8 polymorphisms and risk of oral squamous cell carcinoma.

Authors:  Y I Tang; Yang Liu; Wei Zhao; Tao Yu; Haiyang Yu
Journal:  Exp Ther Med       Date:  2015-10-26       Impact factor: 2.447

7.  Association of CASP9, CASP10 gene polymorphisms and tea drinking with colorectal cancer risk in the Han Chinese population.

Authors:  He Liu; Xia Jiang; Ming-wu Zhang; Yi-feng Pan; Yun-xian Yu; Shan-chun Zhang; Xin-yuan Ma; Qi-long Li; Kun Chen
Journal:  J Zhejiang Univ Sci B       Date:  2013-01       Impact factor: 3.066

8.  11q13 is a susceptibility locus for hormone receptor positive breast cancer.

Authors:  Diether Lambrechts; Therese Truong; Christina Justenhoven; Manjeet K Humphreys; Jean Wang; John L Hopper; Gillian S Dite; Carmel Apicella; Melissa C Southey; Marjanka K Schmidt; Annegien Broeks; Sten Cornelissen; Richard van Hien; Elinor Sawyer; Ian Tomlinson; Michael Kerin; Nicola Miller; Roger L Milne; M Pilar Zamora; José Ignacio Arias Pérez; Javier Benítez; Ute Hamann; Yon-Dschun Ko; Thomas Brüning; Jenny Chang-Claude; Ursel Eilber; Rebecca Hein; Stefan Nickels; Dieter Flesch-Janys; Shan Wang-Gohrke; Esther M John; Alexander Miron; Robert Winqvist; Katri Pylkäs; Arja Jukkola-Vuorinen; Mervi Grip; Georgia Chenevix-Trench; Jonathan Beesley; Xiaoqing Chen; Florence Menegaux; Emilie Cordina-Duverger; Chen-Yang Shen; Jyh-Cherng Yu; Pei-Ei Wu; Ming-Feng Hou; Irene L Andrulis; Teresa Selander; Gord Glendon; Anna Marie Mulligan; Hoda Anton-Culver; Argyrios Ziogas; Kenneth R Muir; Artitaya Lophatananon; Suthee Rattanamongkongul; Puttisak Puttawibul; Michael Jones; Nicholas Orr; Alan Ashworth; Anthony Swerdlow; Gianluca Severi; Laura Baglietto; Graham Giles; Melissa Southey; Federik Marmé; Andreas Schneeweiss; Christof Sohn; Barbara Burwinkel; Betul T Yesilyurt; Patrick Neven; Robert Paridaens; Hans Wildiers; Hermann Brenner; Heiko Müller; Volker Arndt; Christa Stegmaier; Alfons Meindl; Sarah Schott; Claus R Bartram; Rita K Schmutzler; Angela Cox; Ian W Brock; Graeme Elliott; Simon S Cross; Peter A Fasching; Ruediger Schulz-Wendtland; Arif B Ekici; Matthias W Beckmann; Olivia Fletcher; Nichola Johnson; Isabel Dos Santos Silva; Julian Peto; Heli Nevanlinna; Taru A Muranen; Kristiina Aittomäki; Carl Blomqvist; Thilo Dörk; Peter Schürmann; Michael Bremer; Peter Hillemanns; Natalia V Bogdanova; Natalia N Antonenkova; Yuri I Rogov; Johann H Karstens; Elza Khusnutdinova; Marina Bermisheva; Darya Prokofieva; Shamil Gancev; Anna Jakubowska; Jan Lubinski; Katarzyna Jaworska; Katarzyna Durda; Børge G Nordestgaard; Stig E Bojesen; Charlotte Lanng; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Paolo Radice; Paolo Peterlongo; Siranoush Manoukian; Loris Bernard; Fergus J Couch; Janet E Olson; Xianshu Wang; Zachary Fredericksen; Grethe Grenaker Alnaes; Vessela Kristensen; Anne-Lise Børresen-Dale; Peter Devilee; Robert A E M Tollenaar; Caroline M Seynaeve; Maartje J Hooning; Montserrat García-Closas; Stephen J Chanock; Jolanta Lissowska; Mark E Sherman; Per Hall; Jianjun Liu; Kamila Czene; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Annika Lindblom; Sara Margolin; Alison M Dunning; Paul D P Pharoah; Douglas F Easton; Pascal Guénel; Hiltrud Brauch
Journal:  Hum Mutat       Date:  2012-04-30       Impact factor: 4.878

9.  Fine-mapping CASP8 risk variants in breast cancer.

Authors:  Nicola J Camp; Marina Parry; Stacey Knight; Ryan Abo; Graeme Elliott; Sushilaben H Rigas; Sabapathy P Balasubramanian; Malcolm W R Reed; Helen McBurney; Ayse Latif; William G Newman; Lisa A Cannon-Albright; D Gareth Evans; Angela Cox
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-11-04       Impact factor: 4.254

10.  Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.

Authors:  Christoph Engel; Beatrix Versmold; Barbara Wappenschmidt; Jacques Simard; Douglas F Easton; Susan Peock; Margaret Cook; Clare Oliver; Debra Frost; Rebecca Mayes; D Gareth Evans; Rosalind Eeles; Joan Paterson; Carole Brewer; Lesley McGuffog; Antonis C Antoniou; Dominique Stoppa-Lyonnet; Olga M Sinilnikova; Laure Barjhoux; Marc Frenay; Cécile Michel; Dominique Leroux; Helene Dreyfus; Christine Toulas; Laurence Gladieff; Nancy Uhrhammer; Yves-Jean Bignon; Alfons Meindl; Norbert Arnold; Raymonda Varon-Mateeva; Dieter Niederacher; Sabine Preisler-Adams; Karin Kast; Helmut Deissler; Christian Sutter; Dorothea Gadzicki; Georgia Chenevix-Trench; Amanda B Spurdle; Xiaoqing Chen; Jonathan Beesley; Håkan Olsson; Ulf Kristoffersson; Hans Ehrencrona; Annelie Liljegren; Rob B van der Luijt; Theo A van Os; Flora E van Leeuwen; Susan M Domchek; Timothy R Rebbeck; Katherine L Nathanson; Ana Osorio; Teresa Ramón y Cajal; Irene Konstantopoulou; Javier Benítez; Eitan Friedman; Bella Kaufman; Yael Laitman; Phuong L Mai; Mark H Greene; Heli Nevanlinna; Kristiina Aittomäki; Csilla I Szabo; Trinidad Caldes; Fergus J Couch; Irene L Andrulis; Andrew K Godwin; Ute Hamann; Rita K Schmutzler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-10-26       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.